Scientists have developed a wireless, handheld, and non-invasive device that may be able to detect biomarkers for Alzheimer's and Parkinson's disease early.
Researchers at Indiana University School of Medicine will play key roles in a national consortium led by Wake Forest University School of Medicine to study the use, interpretation and implementation of biomarkers to diagnose Alzheimer's disease.
Three of four blood tests used to identify people in early stage Alzheimer’s perform differently in Black people, putting them at risk for misdiagnosis.
Three experimental blood tests used to identify people in early stages of Alzheimer's disease perform differently in Black individuals compared to white individuals, according to a new study from Washington University School of Medicine in St. Louis.